Hansa Biopharma
Develops immunomodulating therapies for rare autoimmune conditions, transplant rejection and cancer.
HQ location
Lund Municipality, Sweden
Website
Launch date
Employees
Market cap
$214m
Enterprise value
$307m
Share price
SEK26.20 HNSA.ST
Company register number
556734-5359
Authorizing premium user...